You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 40 No. 5, May 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Dexamethasone Suppression Tests in Antidepressant Treatment of Melancholia

The Process of Normalization and Test-Retest Reproducibility

John F. Greden, MD; Robert Gardner, PhD; Doug King, MD; Leon Grunhaus, MD; Bernard J. Carroll, MD, PhD; Ziad Kronfol, MD

Arch Gen Psychiatry. 1983;40(5):493-500.


Abstract

• Pilot studies suggest that changes in response to the dexamethasone suppression test (DST) in melancholic patients receiving antidepressants might represent a laboratory marker of clinical progress. We performed weekly DSTs in 31 hospitalized patients with major depressive disorder, primary and endogenous subtypes, during drug-free and subsequent treatment periods. Most nonsuppressors had progressive normalization of DST responses in conjunction with clinical improvement, DST normalization usually preceded or coincided with good clinical response, and failure to normalize was often associated with poorer clinical outcome. Occasional patients with baseline dexamethasone suppression become nonsuppressive after withdrawal from medication, but the DST has no apparent value as a serial marker in patients with welldocumented normal DST findings. Our results extend the construct validity of the DST as a state-related marker in nonsuppressors and suggest future clinical applications.



Author Affiliations

From the Clinical Studies Unit (Drs Greden, Gardner, King, Grunhaus, and Carroll) and Mental Health Research Institute (Drs Greden and Carroll), Department of Psychiatry, University of Michigan, Ann Arbor, and the Department of Psychiatry, University of Iowa Hospitals and Clinics, Iowa City (Dr Kronfol).


Footnotes

Accepted for publication Jan 3, 1983.

Reprint requests to Clinical Studies Unit, Department of Psychiatry (N5739), University of Michigan Hospitals, Ann Arbor, MI 48109 (Dr Greden).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Impact of Sleep Deprivation and Subsequent Recovery Sleep on Cortisol in Unmedicated Depressed Patients
Voderholzer et al.
Am. J. Psychiatry 2004;161:1404-1410.
ABSTRACT | FULL TEXT  

When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders
Raison and Miller
Am. J. Psychiatry 2003;160:1554-1565.
ABSTRACT | FULL TEXT  

Treatment of Depression With Antiglucocorticoid Drugs
Wolkowitz and Reus
Psychosom. Med. 1999;61:698-711.
ABSTRACT | FULL TEXT  

Hypothalamic-Pituitary-Adrenocortical Axis Changes in a Transgenic Mouse with Impaired Glucocorticoid Receptor Function
Karanth et al.
Endocrinology 1997;138:3476-3485.
ABSTRACT | FULL TEXT  

Serial Dexamethasone Suppression Tests and Plasma Dexamethasone Levels: Effects of Clinical Response to Electroconvulsive Therapy in Major Depression
Devanand et al.
Arch Gen Psychiatry 1991;48:525-533.
ABSTRACT  

Recurrent Depression Is Associated With a Persistent Reduction in Sleep-Related Growth Hormone Secretion
Jarrett et al.
Arch Gen Psychiatry 1990;47:113-118.
ABSTRACT  

Cortisol Secretion in Prepubertal Children With Major Depressive Disorder: Episode and Recovery
Puig-Antich et al.
Arch Gen Psychiatry 1989;46:801-809.
ABSTRACT  

Predictors of Drug Response in Depression
Joyce and Paykel
Arch Gen Psychiatry 1989;46:89-99.
ABSTRACT  

Enhanced Adrenal Sensitivity to Exogenous Cosyntropin (ACTH {alpha}1-24) Stimulation in Major Depression: Relationship to Dexamethasone Suppression Test Results
Jaeckle et al.
Arch Gen Psychiatry 1987;44:233-240.
ABSTRACT  

The Dexamethasone Suppression Test for Diagnosis and Prognosis in Psychiatry: Commentary and Review
Arana et al.
Arch Gen Psychiatry 1985;42:1193-1204.
ABSTRACT  

Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
Nemeroff et al.
Science 1984;226:1342-1344.
ABSTRACT  

The Price of Beer and the Salaries of Priests: Analysis and Display of Longitudinal Psychiatric Data
Gibbons and Davis
Arch Gen Psychiatry 1984;41:1183-1184.
ABSTRACT  

Errors in Administration of the Dexamethasone Suppression Test
Dewan et al.
Arch Gen Psychiatry 1984;41:725-725.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.